Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. (Q34251507)

31 July 2017

title

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. (English)

1 reference

31 July 2017

0 references

1 reference

Dagny Faksvåg Haugen

0 references

Pål Klepstad

Pål Klepstad

0 references

Ola Dale

Ola Dale

0 references

Stein Kaasa

Stein Kaasa

0 references

Franco De Conno

Franco De Conno

0 references

Alessandra Pigni

0 references

Patrick C Stone

0 references

Nathan Cherny

0 references

Augusto Caraceni

0 references

Michael I Bennett

0 references

Sebastiano Mercadante

Sebastiano Mercadante

1 reference

31 July 2017

Geoffrey Hanks

1 reference

31 July 2017

0 references

Lukas Radbruch

1 reference

31 July 2017

Cinzia Brunelli

1 reference

31 July 2017

Marie Fallon

1 reference

31 July 2017

Magdi Hanna

1 reference

31 July 2017

Gitte Juhl

1 reference

31 July 2017

Samuel King

1 reference

31 July 2017

Eivor A Laugsand

1 reference

31 July 2017

Marco Maltoni

1 reference

31 July 2017

Maria Nabal

1 reference

31 July 2017

Colette Reid

1 reference

31 July 2017

Per Sjogren

1 reference

31 July 2017

Davide Tassinari

1 reference

31 July 2017

Giovambattista Zeppetella

1 reference

31 July 2017

European Palliative Care Research Collaborative (EPCRC)

1 reference

31 July 2017

European Association for Palliative Care (EAPC)

1 reference

31 July 2017

publication date

1 February 2012

1 reference

Lancet Oncology Commission

31 July 2017

published in

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

e58-68

1 reference

A validation study of the WHO method for cancer pain relief

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Prevalence of undertreatment in cancer pain. A review of published literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Cancer pain assessment in clinical trials. A review of the literature (1999-2002).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Morphine and alternative opioids in cancer pain: the EAPC recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Update on Cancer Pain Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

What is "quality of evidence" and why is it important to clinicians?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Going from evidence to recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Incorporating considerations of resources use into grading recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

The second step of the analgesic ladder and oral tramadol in the treatment of mild to moderate cancer pain: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Starting step III opioids for moderate to severe pain in cancer patients: dose titration: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

European Palliative Care Research collaborative pain guidelines. Central side-effects management: what is the evidence to support best practice in the management of sedation, cognitive impairment and myoclonus?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

A systematic review of oxycodone in the management of cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

The role of hydromorphone in cancer pain treatment: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Transdermal opioids as front line treatment of moderate to severe cancer pain: a systemic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Is oral methadone better than placebo or other oral/transdermal opioids in the management of pain?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

European Palliative Care Research Collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Opioids for the management of breakthrough cancer pain in adults: a systematic review undertaken as part of an EPCRC opioid guidelines project

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Spinal opioids in adult patients with cancer pain: a systematic review: a European Palliative Care Research Collaborative (EPCRC) opioid guidelines project

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Systematic review of the role of alternative application routes for opioid treatment for moderate to severe cancer pain: an EPCRC opioid guidelines project

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

A systematic review of combination step III opioid therapy in cancer pain: an EPCRC opioid guideline project.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

The effects of liver impairment on opioids used to relieve pain in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Laxatives or methylnaltrexone for the management of constipation in palliative care patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

The dose-response relationship of controlled-release codeine (Codeine Contin) in chronic cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Incidence of weak opioids adverse events in the management of cancer pain: a double-blind comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Oral tramadol, a mu-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

A validation study of the WHO analgesic ladder: a two-step vs three-step strategy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Use of strong opioids in advanced cancer pain: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Oral morphine for cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during 'titration phase' in patients with cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Intravenous morphine for rapid control of severe cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Treatment of cancer pain with transdermal fentanyl

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Methadone for cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

A randomized study on oral administration of morphine and methadone in the treatment of cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Choice of strong analgesic in terminal cancer: diamorphine or morphine?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Opioid rotation: the science and the limitations of the equianalgesic dose table

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Opioid switching to improve pain relief and drug tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Use of the subcutaneous route for the administration of narcotics in patients with cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Hydromorphone for acute and chronic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Continuous subcutaneous infusion of opiates at end-of-life

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Intravenous versus subcutaneous morphine titration in patients with persisting exacerbation of cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

The role of patient-controlled analgesia in the management of cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Comparison of hydromorphone continuous subcutaneous infusion and basal rate subcutaneous infusion plus PCA in cancer pain: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Patient-controlled analgesia for chronic cancer pain in the ambulatory setting: a report of 117 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Patient-controlled analgesia (PCA) in the domiciliary care of tumour patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Assessment and classification of cancer breakthrough pain: a systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Opioids for the management of breakthrough (episodic) pain in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension tr

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

An Italian survey on the attitudes in treating breakthrough cancer pain in hospice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: A long-term, open-label safety study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Intravenous morphine for breakthrough (episodic-) pain in an acute palliative care unit: a confirmatory study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Methylnaltrexone for opioid-induced constipation in advanced illness

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

NSAIDS or paracetamol, alone or combined with opioids, for cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Pharmacological management of persistent pain in older persons

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Expert conference on cancer pain assessment and classification--the need for international consensus: working proposals on international standards

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

Symptom assessment in palliative care: a need for international collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970040-2

7 January 2021

10.1016/S1470-2045(12)70040-2

Identifiers

DOI

1 reference

31 July 2017

1 reference